Cargando…

The oncometabolite R-2-hydroxyglutarate dysregulates the differentiation of human mesenchymal stromal cells via inducing DNA hypermethylation

BACKGROUND: Isocitrate dehydrogenase (IDH1/2) gene mutations are the most frequently observed mutations in cartilaginous tumors. The mutant IDH causes elevation in the levels of R-enantiomer of 2-hydroxylglutarate (R-2HG). Mesenchymal stromal cells (MSCs) are reasonable precursor cell candidates of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lizhen, Hu, Kaimin, Feng, Jingjing, Wang, Huafang, Fu, Shan, Wang, Binsheng, Wang, Limengmeng, Xu, Yulin, Yu, Xiaohong, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791852/
https://www.ncbi.nlm.nih.gov/pubmed/33413208
http://dx.doi.org/10.1186/s12885-020-07744-x
_version_ 1783633681494048768
author Liu, Lizhen
Hu, Kaimin
Feng, Jingjing
Wang, Huafang
Fu, Shan
Wang, Binsheng
Wang, Limengmeng
Xu, Yulin
Yu, Xiaohong
Huang, He
author_facet Liu, Lizhen
Hu, Kaimin
Feng, Jingjing
Wang, Huafang
Fu, Shan
Wang, Binsheng
Wang, Limengmeng
Xu, Yulin
Yu, Xiaohong
Huang, He
author_sort Liu, Lizhen
collection PubMed
description BACKGROUND: Isocitrate dehydrogenase (IDH1/2) gene mutations are the most frequently observed mutations in cartilaginous tumors. The mutant IDH causes elevation in the levels of R-enantiomer of 2-hydroxylglutarate (R-2HG). Mesenchymal stromal cells (MSCs) are reasonable precursor cell candidates of cartilaginous tumors. This study aimed to investigate the effect of oncometabolite R-2HG on MSCs. METHODS: Human bone marrow MSCs treated with or without R-2HG at concentrations 0.1 to 1.5 mM were used for experiments. Cell Counting Kit-8 was used to detect the proliferation of MSCs. To determine the effects of R-2HG on MSC differentiation, cells were cultured in osteogenic, chondrogenic and adipogenic medium. Specific staining approaches were performed and differentiation-related genes were quantified. Furthermore, DNA methylation status was explored by Illumina array-based arrays. Real-time PCR was applied to examine the signaling component mRNAs involved in. RESULTS: R-2HG showed no influence on the proliferation of human MSCs. R-2HG blocked osteogenic differentiation, whereas promoted adipogenic differentiation of MSCs in a dose-dependent manner. R-2HG inhibited chondrogenic differentiation of MSCs, but increased the expression of genes related to chondrocyte hypertrophy in a lower concentration (1.0 mM). Moreover, R-2HG induced a pronounced DNA hypermethylation state of MSC. R-2HG also improved promotor methylation of lineage-specific genes during osteogenic and chondrogenic differentiation. In addition, R-2HG induced hypermethylation and decreased the mRNA levels of SHH, GLI1and GLI2, indicating Sonic Hedgehog (Shh) signaling inhibition. CONCLUSIONS: The oncometabolite R-2HG dysregulated the chondrogenic and osteogenic differentiation of MSCs possibly via induction of DNA hypermethylation, improving the role of R-2HG in cartilaginous tumor development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-020-07744-x.
format Online
Article
Text
id pubmed-7791852
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77918522021-01-11 The oncometabolite R-2-hydroxyglutarate dysregulates the differentiation of human mesenchymal stromal cells via inducing DNA hypermethylation Liu, Lizhen Hu, Kaimin Feng, Jingjing Wang, Huafang Fu, Shan Wang, Binsheng Wang, Limengmeng Xu, Yulin Yu, Xiaohong Huang, He BMC Cancer Research Article BACKGROUND: Isocitrate dehydrogenase (IDH1/2) gene mutations are the most frequently observed mutations in cartilaginous tumors. The mutant IDH causes elevation in the levels of R-enantiomer of 2-hydroxylglutarate (R-2HG). Mesenchymal stromal cells (MSCs) are reasonable precursor cell candidates of cartilaginous tumors. This study aimed to investigate the effect of oncometabolite R-2HG on MSCs. METHODS: Human bone marrow MSCs treated with or without R-2HG at concentrations 0.1 to 1.5 mM were used for experiments. Cell Counting Kit-8 was used to detect the proliferation of MSCs. To determine the effects of R-2HG on MSC differentiation, cells were cultured in osteogenic, chondrogenic and adipogenic medium. Specific staining approaches were performed and differentiation-related genes were quantified. Furthermore, DNA methylation status was explored by Illumina array-based arrays. Real-time PCR was applied to examine the signaling component mRNAs involved in. RESULTS: R-2HG showed no influence on the proliferation of human MSCs. R-2HG blocked osteogenic differentiation, whereas promoted adipogenic differentiation of MSCs in a dose-dependent manner. R-2HG inhibited chondrogenic differentiation of MSCs, but increased the expression of genes related to chondrocyte hypertrophy in a lower concentration (1.0 mM). Moreover, R-2HG induced a pronounced DNA hypermethylation state of MSC. R-2HG also improved promotor methylation of lineage-specific genes during osteogenic and chondrogenic differentiation. In addition, R-2HG induced hypermethylation and decreased the mRNA levels of SHH, GLI1and GLI2, indicating Sonic Hedgehog (Shh) signaling inhibition. CONCLUSIONS: The oncometabolite R-2HG dysregulated the chondrogenic and osteogenic differentiation of MSCs possibly via induction of DNA hypermethylation, improving the role of R-2HG in cartilaginous tumor development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-020-07744-x. BioMed Central 2021-01-07 /pmc/articles/PMC7791852/ /pubmed/33413208 http://dx.doi.org/10.1186/s12885-020-07744-x Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Liu, Lizhen
Hu, Kaimin
Feng, Jingjing
Wang, Huafang
Fu, Shan
Wang, Binsheng
Wang, Limengmeng
Xu, Yulin
Yu, Xiaohong
Huang, He
The oncometabolite R-2-hydroxyglutarate dysregulates the differentiation of human mesenchymal stromal cells via inducing DNA hypermethylation
title The oncometabolite R-2-hydroxyglutarate dysregulates the differentiation of human mesenchymal stromal cells via inducing DNA hypermethylation
title_full The oncometabolite R-2-hydroxyglutarate dysregulates the differentiation of human mesenchymal stromal cells via inducing DNA hypermethylation
title_fullStr The oncometabolite R-2-hydroxyglutarate dysregulates the differentiation of human mesenchymal stromal cells via inducing DNA hypermethylation
title_full_unstemmed The oncometabolite R-2-hydroxyglutarate dysregulates the differentiation of human mesenchymal stromal cells via inducing DNA hypermethylation
title_short The oncometabolite R-2-hydroxyglutarate dysregulates the differentiation of human mesenchymal stromal cells via inducing DNA hypermethylation
title_sort oncometabolite r-2-hydroxyglutarate dysregulates the differentiation of human mesenchymal stromal cells via inducing dna hypermethylation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791852/
https://www.ncbi.nlm.nih.gov/pubmed/33413208
http://dx.doi.org/10.1186/s12885-020-07744-x
work_keys_str_mv AT liulizhen theoncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT hukaimin theoncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT fengjingjing theoncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT wanghuafang theoncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT fushan theoncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT wangbinsheng theoncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT wanglimengmeng theoncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT xuyulin theoncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT yuxiaohong theoncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT huanghe theoncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT liulizhen oncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT hukaimin oncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT fengjingjing oncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT wanghuafang oncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT fushan oncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT wangbinsheng oncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT wanglimengmeng oncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT xuyulin oncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT yuxiaohong oncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation
AT huanghe oncometaboliter2hydroxyglutaratedysregulatesthedifferentiationofhumanmesenchymalstromalcellsviainducingdnahypermethylation